Exclusive

Publication

Byline

Location

US Patent Issued to TETRAGON BIOSCIENCE on April 21 for "Deoxy-cytidine or uridine derivatives for use in cancer therapies" (Null, Norwegian Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,397, issued on April 21, was assigned to TETRAGON BIOSCIENCE LTD. (Modi'in, Israel). "Deoxy-cytidine or uridine derivatives for use in can... Read More


US Patent Issued to The Administrators of the Tulane Educational Fund, NATIONAL INSTITUTES OF HEALTH (NIH), U.S DEPT OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT on April 21 for "CRISPR-based compositions for treating vascular disorders" (Louisiana Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,398, issued on April 21, was assigned to The Administrators of the Tulane Educational Fund (New Orleans) and NATIONAL INSTITUTES OF HEALTH ... Read More


US Patent Issued to TRANSLATE BIO on April 21 for "Compositions for CFTR MRNA therapy" (Massachusetts Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,399, issued on April 21, was assigned to TRANSLATE BIO INC. (Waltham, Mass.). "Compositions for CFTR MRNA therapy" was invented by Anusha ... Read More


US Patent Issued to RACTIGEN THERAPEUTICS on April 21 for "Oligomeric nucleic acid molecule, and application thereof in an acute intermittent porphyria treatment" (Chinese Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,400, issued on April 21, was assigned to RACTIGEN THERAPEUTICS (Nantong City, China). "Oligomeric nucleic acid molecule, and application t... Read More


US Patent Issued to WATERSTONE PHARMACEUTICALS (WUHAN) on April 21 for "Polymers, compositions and methods for treating hyperuricemia" (Chinese Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,401, issued on April 21, was assigned to WATERSTONE PHARMACEUTICALS (WUHAN) Co. LTD. (Wuhan, China). "Polymers, compositions and methods f... Read More


US Patent Issued to APR Applied Pharma Research on April 21 for "Therapeutic uses of oxidizing hypotonic acid solutions" (Swiss, Italian Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,402, issued on April 21, was assigned to APR Applied Pharma Research SA (Geneva). "Therapeutic uses of oxidizing hypotonic acid solutions"... Read More


US Patent Issued to WIAB WATER INNOVATION on April 21 for "Compositions and methods for treating transient biofilms" (Norwegian Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,403, issued on April 21, was assigned to WIAB WATER INNOVATION AB (Malmo, Sweden). "Compositions and methods for treating transient biofil... Read More


US Patent Issued to Ionic Alliance Foundation on April 21 for "Synthetic cellular membrane chemical ionophore delivery system comprising hexa-aqua ligand compositions" (Michigan, Colorado Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,404, issued on April 21, was assigned to Ionic Alliance Foundation Inc (Indian Hills, Colo.). "Synthetic cellular membrane chemical ionoph... Read More


US Patent Issued to ORTHOGEN on April 21 for "Methods for the production of pharmaceutical agents" (German Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,405, issued on April 21, was assigned to ORTHOGEN AG (Dusseldorf, Germany). "Methods for the production of pharmaceutical agents" was inve... Read More


US Patent Issued to The Trustees of Columbia University in the City of New York on April 21 for "Methods to induce terminal differentiation in stem cells by interfering with DNA replication, methods of inducing pancreatic differentiation, and differentiated cells obtained thereof" (New York, New Jersey Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,407, issued on April 21, was assigned to The Trustees of Columbia University in the City of New York (New York). "Methods to induce termin... Read More